714 Mrv0541 02231214572D 21 24 0 0 1 0 999 V2000 3.4218 1.3849 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.0105 0.5846 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 6.1725 -1.0164 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 5.4927 -0.6228 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 5.4927 0.1694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.8067 -1.0188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.2135 0.5708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.8581 -0.6328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.8784 0.1524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.8067 0.5654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1207 -0.6228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.1207 0.1694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.1667 -1.8084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.2199 1.3959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.7940 1.3904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.4126 -1.0462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.4126 0.5929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.5053 1.8084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6949 0.1858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6949 -0.6392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4923 -1.2564 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1 17 1 0 0 0 0 2 19 1 0 0 0 0 3 4 1 0 0 0 0 3 8 1 0 0 0 0 3 13 1 0 0 0 0 4 5 1 0 0 0 0 4 6 1 0 0 0 0 4 21 1 1 0 0 0 5 7 2 0 0 0 0 5 10 1 0 0 0 0 6 11 1 0 0 0 0 7 9 1 0 0 0 0 7 14 1 0 0 0 0 8 9 1 0 0 0 0 10 12 1 0 0 0 0 10 15 2 0 0 0 0 11 12 2 0 0 0 0 11 16 1 0 0 0 0 12 17 1 0 0 0 0 14 18 2 0 0 0 0 15 18 1 0 0 0 0 16 20 2 0 0 0 0 17 19 2 0 0 0 0 19 20 1 0 0 0 0 M END > DB00714 > drugbank > [H][C@]12CC3=C(C(O)=C(O)C=C3)C3=CC=CC(CCN1C)=C23 > InChI=1S/C17H17NO2/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12/h2-6,13,19-20H,7-9H2,1H3/t13-/m1/s1 > VMWNQDUVQKEIOC-CYBMUJFWSA-N > C17H17NO2 > 267.3224 > 267.125928793 > 3 > 37 > 0.8343256126182149 > 29.695470396621204 > 1 > 2 > 0 > 1 > (9R)-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(16),2(7),3,5,13(17),14-hexaene-3,4-diol > 2.51 > 2.877939980284464 > -2.72 > 0 > 1 > 4 > 1 > 12.67552037596164 > 9.255194516228293 > 7.720459090323013 > 43.7 > 79.98810000000002 > 0 > 1 > 5.10e-01 g/l > tetrahydrofolic acid > 0 > DB00714 > APRD00531; DB05816 > approved; investigational > Apomorphine > (−)-10,11-dihydroxyaporphine; (6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol; (R)-5,6,6a,7-tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol; Apomorfina; Apomorphin; Apomorphine; R-(−)-apomorphine > Apokyn; Apomorphine Hydrocloride; Kynmobi; Movapo > Ixense; Spontane; Uprima > Apomorphine hydrochloride $$$$